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Naive T cell recirculation is primarily restricted 
to  secondary  lymphoid  tissues,  blood,  and 
lymph (Butcher and Picker, 1996; von Andrian 
and Mackay, 2000). However, most infections 
are initiated at body surfaces, including the gut 
(Neutra and Kozlowski, 2006). Before CD8 T 
cells can participate in the eradication of local 
infections, microbial antigen must get from the 
site of infection to secondary lymphoid tissue, 
cognate antigen-specific T cells must undergo 
activation and expansion, and then CD8 T cells 
must migrate to the site of infection to effect 
pathogen clearance. Because these events con-
sume valuable time, it is perhaps not surprising 
that a portion of memory T cells remain distrib-
uted at body surfaces after primary infections, 
where they may be better positioned to respond 
immediately in the event of reinfection (Hogan 
et al., 2001; Masopust et al., 2001b; Reinhardt 
et al., 2001). In support of this hypothesis, mem-
ory CD8 T cells within the gut epithelium   
(intraepithelial lymphocytes [IELs]) are function-
ally distinct from those in lymphoid tissue and 
exhibit immediate cytotoxicity upon reinfection 
(Kim et al., 1999; Masopust et al., 2001a). The 
vulnerability of the intestinal mucosa to infection 
because  of  its  proximity  with  the  microbial 
world, large surface area, and identity as a major 
reservoir of HIV infection, and the putative 
role that in situ memory T cells play in protec-
tion, have provided substantial motivation to   
understand how memory is established and 
maintained at such body surfaces (Hayday et al., 
2001;  Nagler-Anderson,  2001;  Belyakov  and 
Berzofsky, 2004; Cheroutre, 2005; Haase, 2005; 
Liu et al., 2006; Gebhardt et al., 2009).
T cells use 47 integrin and CCR9 to 
migrate to small intestine epithelium, and they 
use different homing receptors, such as cutaneous 
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Migration to intestinal mucosa putatively depends on local activation because gastrointes-
tinal lymphoid tissue induces expression of intestinal homing molecules, whereas skin-draining 
lymph nodes do not. This paradigm is difficult to reconcile with reports of intestinal T cell 
responses after alternative routes of immunization. We reconcile this discrepancy by demon-
strating that activation within spleen results in intermediate induction of homing potential 
to the intestinal mucosa. We further demonstrate that memory T cells within small intestine 
epithelium do not routinely recirculate with memory T cells in other tissues, and we provide 
evidence that homing is similarly dynamic in humans after subcutaneous live yellow fever 
vaccine immunization. These data explain why systemic immunization routes induce local 
cell-mediated immunity within the intestine and indicate that this tissue must be seeded 
with memory T cell precursors shortly after activation.
©  2010  Masopust  et  al.  This  article  is  distributed  under  the  terms  of  an   
Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six 
months after the publication date (see http://www.rupress.org/terms). After six 
months it is available under a Creative Commons License (Attribution–Noncom-
mercial–Share Alike 3.0 Unported license, as described at http://creativecommons 
.org/licenses/by-nc-sa/3.0/).
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epithelial memory CD8 T cell populations are established,   
instructed to express unique properties, and maintained, we 
investigated whether priming within GALT is required for 
CD8 T cell migration to small intestine and also whether IELs 
routinely recirculate or are long-term residents.
RESULTS
Dynamic T cell migration program in spleen
To examine the dynamics of CD8 T cell homing, we used 
the lymphocytic choriomeningitis virus (LCMV) and P14 
transgenic CD8 T cell system, which provides access to large 
numbers  of  naive,  effector,  and  memory  CD8  T  cells  of 
known specificity. To generate effector and memory CD8 T 
cells,  naive  Thy1.1+  P14  were  transferred  to  naive  mice, 
which were then challenged i.p. with the Armstrong strain   
of LCMV. In response to infection, P14 underwent clonal   
expansion, which peaked 7 d after challenge, followed by 
contraction of the population and formation of stable mem-
ory by 1 mo later (Fig. 1 A). We first examined the trafficking 
potential of cells isolated from spleen. We transferred 2 × 106 
naive P14 splenocytes or 2 × 106 P14 splenocytes isolated 
4.5, 7, or 60 d after LCMV Armstrong infection into naive 
Thy1.2+ recipients. It should be noted that day-4.5 CD8 T 
cells represent early effectors that are still undergoing clonal 
expansion. The next day, lymphocytes were harvested from 
recipient tissues (Fig. 1 B).
As expected, naive CD8 T cells populated blood and   
secondary lymphoid tissues but were excluded from the IEL 
compartment of the small intestine (Fig. 1 C and Fig. S1). When 
early effector P14 splenocytes isolated from spleen (or blood; 
Fig. S2) were transferred, they were recovered from spleen and 
the epithelium of the intestinal mucosa. These data demonstrated 
that early effector CD8 T cells were capable of homing from 
spleen to gut. Pertussis toxin treatment of donor cells inhibited 
effector cell homing to intestinal epithelium, demonstrating that 
this migration was chemokine dependent (Fig. S1).
Remarkably, CD8 T cells lost the ability to migrate to the 
IEL compartment by 7 d after infection (Fig. 1 C). Memory CD8 
T cells were entirely excluded from migrating to the intestinal 
epithelium. Thus, CD8 T cells were endowed with the ability to 
migrate to intestinal epithelium only early during the response.
We then tested whether effector cells were contaminated 
with a cofactor that permitted T cells, regardless of differenti-
ation state, to migrate to the intestinal epithelium. When 
day-4.5 and memory P14 splenocytes were mixed and trans-
ferred to the same naive recipient, both populations of cells 
were equivalently recovered from spleen. However, memory 
CD8  T  cells  were  20-fold  more  efficient  at  trafficking   
to LN and early effectors were >50-fold more efficient at 
migrating to the small intestinal epithelium (Fig. S3). This 
indicated that effector and memory CD8 T cells exhibit in-
trinsically different homing properties.
To test this conclusion further, we examined the dynam-
ics of 47 expression, which is required for homing to the 
small intestine. Fig. 1 D shows that 47 expression is tran-
siently up-regulated on all early effector LCMV-specific CD8 
lymphocyte-associated  antigen  (CLA),  to  migrate  to  skin 
(von Andrian and Mackay, 2000; Johansson-Lindbom and 
Agace, 2007). Gut and skin homing receptor expression is 
coupled to the location of T cell activation (Campbell and 
Butcher, 2002; Stagg et al., 2002; Mora et al., 2003, 2005). 
Priming within mesenteric LN (mLN) induces 47 expres-
sion. In contrast, priming within inguinal LN (iLN) induces 
expression  of  skin  homing  molecules.  These  observations 
support the hypothesis that local infection and subsequent 
priming  within  gastrointestinal-associated  lymphoid  tissue 
(GALT) is required for dissemination of CD8 T cells into the 
small intestine. Although numerous observations are consis-
tent with this hypothesis (Gallichan and Rosenthal, 1996; 
Belyakov et al., 1998), there are several examples in which 
alternative routes of immunization result in effector T cell 
responses within the intestinal mucosa (Stevceva et al., 2002; 
Masopust et al., 2004; Liu et al., 2006). Reconciling these 
seemingly disparate observations is essential for understanding 
the relationship between immunization route and the estab-
lishment of local protective cellular immunity.
Another issue of relevance to protective immunity is 
whether  memory  CD8  T  cells  continuously  recirculate   
between blood, lymphoid tissue, and mucosal epithelium or 
whether IELs are long-term sessile residents. Numerous stud-
ies support the general concept that effector memory CD8   
T cells recirculate between nonlymphoid tissues and blood 
(Butcher and Picker, 1996). For instance, if the vasculature of 
two  mice  is  conjoined  via  parabiosis,  preexisting  memory 
CD8 T cells originating from both mice can be isolated from 
a single lung, liver, or peritoneal cavity (Jungi and Jungi, 1981; 
Klonowski et al., 2004), demonstrating that memory cells en-
ter certain tissues via the blood. The memory T cell popula-
tion in lung airways is thought to be short lived but maintained 
by  the  continuous  recruitment  of  the  systemic  population   
(Ely et al., 2006). Memory CD8 T cells also exit tissues using 
afferent lymphatic vessels, which drain interstitial fluid from 
peripheral tissues (Olszewski et al., 1995; Lehmann et al., 2001; 
Bromley et al., 2005; Debes et al., 2005). Indeed, Mackay et al. 
(1990) isolated antigen-experienced lymphocytes directly from 
the hind limb afferent lymphatics of sheep. Memory T cells 
putatively egress with the afferent lymph as it filters through 
proximal LNs, pools within the thoracic duct, and then rejoins 
the blood supply. Thus, memory CD8 T cells in most periph-
eral tissues may be transient visitors, constantly patrolling   
peripheral organs in the event of reinfection.
However, it is unclear whether the recirculation paradigm 
applies to virus-specific memory CD8 IEL. Unlike most 
tissues, including the subjacent lamina propria, this avascular 
compartment consists of T cells residing among a monolayer of 
columnar epithelial cells that lies above a basement membrane 
and lacks blood vessels and afferent lymphatics. Although anti-
gen specificity was not determined, parabiosis studies showed 
limited mixing of IEL between conjoined mice (Klonowski et 
al., 2004). Lastly, memory IELs are phenotypically and func-
tionally distinct from CD8 T cells in blood (Masopust et al., 
2006). As these issues impact our understanding of how JEM VOL. 207, March 15, 2010 
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(7.2 × 106 early effector P14 in spleen versus 3.4 × 105 in mLNs). 
Thus, it is unlikely that activation in GALT was required for 
47 expression. To examine this issue more stringently, 
mice were infected intranasally with influenza virus. 5 d later, 
almost no activated virus-specific CD8 T cells could be   
detected within GALT, yet flu-specific CD8 T cells in spleen- 
and lung-associated tissues expressed 47 and memory CD8 
T cells were established within small intestinal epithelium 
(Fig. 3, A and B). Intramuscular injection of a DNA vaccine 
into the anterior tibialis (located within lower hind limb) also 
led to transient 47 expression and the establishment of 
CD8 T cells within intestinal epithelium (Fig. 3, C and D). 
Moreover, disruption of lymphocyte egress from GALT via 
treatment of mice with FTY720 did not affect 47 expres-
sion among effector CD8 T cells in spleen (Fig. 3 E). Collec-
tively, these data demonstrate that activation in GALT is not 
required for 47 expression among CD8 T cells.
Homing potential among distinct lymphoid tissues
We next tested whether memory CD8 T cells in mucosal   
tissues also lacked 47, and we determined the dynamics of 
CCR9 expression, which is also involved in migration to gut 
(Zabel et al., 1999; Kunkel et al., 2000; Johansson-Lindbom 
T splenocytes and is then rapidly down-regulated. Thus, the 
timing of 47 expression reflected the transient ability of T 
cells to traffic to the gut epithelium.
We then tested whether reactivation of memory CD8 T 
cells would result in transient reexpression of 47. Spleno-
cytes isolated from LCMV-immune Thy1.1+ P14 chimeras 
(Fig. 1) were transferred to naive mice. Recipients were boosted 
the next day with pathogens that contained cognate gp33 anti-
gen, including LCMV Armstrong strain, LCMV clone 13 
strain, or recombinant Listera monocytogenes (LM-gp33). In each 
case, secondary donor CD8 T cell responses were coupled 
with transient reexpression of 47 and dissemination into the 
small intestinal epithelium (Fig. 2). Endogenous H-2Db/
gp33-specific reactivated memory CD8 T cells also transiently 
up-regulated 47 upon boosting (Fig. 2), so this phenome-
non was not unique to transgenic CD8 T cells. In contrast, 
challenge with LM that lacked recombinant cognate gp33 anti-
gen (LM-WT) failed to induce 47 expression among mem-
ory  P14,  suggesting  that  the  infectious  milieu  alone  was 
insufficient and that cognate antigen was required.
It should be noted that LCMV infects the spleen, almost 
100% of early effector splenocytes expressed 47, and there 
are 20-fold more early effectors in spleen than GALT 
Figure 1.  Only early effector CD8 T cells migrate to intestinal epithelium and express 47. (A) Dynamics of P14 response to LCMV. The day 37 
time point represents 12 mice analyzed from days 31 to 50 after infection. (B) Experimental design consists of transferring P14 at different stages of  
differentiation and harvesting tissues the next day. (C) Numbers of naive (N), effector (isolated 4.5 or 7 d after infection), and memory (isolated 60 d after 
infection) cells isolated from recipient spleen and intestinal epithelium (IEL). ns, not significant, *, P < 0.05; **, P < 0.01, unpaired Student’s t test. Error 
bars indicate SEM. (D) Virus-specific P14 CD8 T cells were analyzed for expression of 47. gmfi, geometric mean fluorescence intensity of 47  
staining. All plots are gated on Thy1.1+ CD8+ lymphocytes and are representative of at least three independent experiments totaling >10 mice/time point.556 Resident mucosal memory from systemic immunization | Masopust et al.
We then determined whether 47 expression was main-
tained on memory CD8 T cells after oral infection. OT-I 
transgenic CD8 T cells specific for ovalbumin were trans-
ferred to mice before oral infection with recombinant LM 
expressing ovalbumin (LM-ova; Masopust et al., 2001a; Pope 
et al., 2001). As shown in Fig. 4 B, memory CD8 T cells   
did not retain 47 after oral infection in any tissue analyzed, 
including the IEL compartment.
and Agace, 2007). Fig. 4 A demonstrates that neither 47 
nor CCR9 expression is maintained on memory CD8 T cells 
isolated from any lymphoid tissue. Although IEL memory 
CD8 T cells expressed CCR9, 47 was down-regulated   
by day 7 after infection (Fig. 4 and Fig. S4). Thus, LCMV-
specific memory CD8 T cells, regardless of location, did not 
coexpress the essential homing molecules required for entry 
into the intestinal mucosa.
Figure 2.  Antigen-dependent reexpression of 47 by spleen-derived transgenic and endogenous memory CD8 T cells upon infection with 
virus or bacteria. (A–D) Splenocytes isolated from P14 immune chimeras (>30 d after LCMV Arm infection) were transferred to naive recipients.  
(A and B) The next day, recipients were challenged with high-dose LCMV Arm or left unchallenged. (A) 47 expression was monitored in blood among 
donor P14 (Thy1.1+/gp33 tetramer+), nontransgenic gp33-specific cells (Thy1.1/gp33 tetramer+), and CD44lo (naive) CD8 T cells. Representative flow cytometry 
data are shown. (B) Change in GMFI of 47 expression relative to 47 GMFI of memory P14 transferred to unchallenged mice that were analyzed on 
the same day. (C and D) As in A and B, except mice were challenged with LCMV Cl13 (C) or LM-gp33 (D), or the noncognate antigen bearing inflamma-
tion control LM-WT. (E) 19 d after infection, small intestine IEL of these mice were examined for the presence of donor P14. (F) Splenocytes from LCMV 
Arm–immune C57BL/6J mice (which did not contain P14) were transferred to naive CD45.1 recipients. Recipients were challenged the next day with LM-
gp33, and 47 expression among CD45.1 gp33-tetramer+ CD8 T cells was monitored in blood. At least three mice were analyzed at each time point in 
each experiment. Error bars indicate SEM. One of two experiments with similar results is shown.JEM VOL. 207, March 15, 2010 
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CCR9 than those isolated from spleen or iLN. We compared the 
homing potential of each population on a per cell basis by trans-
ferring 106 P14 isolated from each lymphoid tissue 4.5 d after 
LCMV infection to separate recipients (Fig. 4 C). With regard to 
Expression of gut homing molecules on early effector CD8 
T cells varied by location (Fig. 4, A and B). Those isolated from 
skin-draining iLN up-regulated less 47 than cells in spleen and 
mLN. And early effectors in mLN expressed higher levels of 
Figure 3.  Memory CD8 T cells do not retain 47 expression regardless of anatomical location or immunization route. Naive Thy1.1+ P14 
were transferred to naive mice. (A and B) The next day, mice were infected intranasally with 500 pfu of recombinant influenza virus that expresses gp33. 
5 (A) or 86 (B) d later, lymphocytes were isolated from the indicated tissues and stained with -Thy1.1, CD8, and 47 or CD44. Plots are gated on CD8+ 
lymphocytes. (C and D) Alternatively, 200 µg DNA that expresses the glycoprotein of LCMV under control of the CMVie promoter was administered  
intramuscularly into both anterior tibialis muscles. (C) 9 and 12 d later, Thy1.1+ cells were examined for expression of 47 (gated on CD8+ Thy1.1+  
lymphocytes). (D) 12 d after immunization, lymphocytes were isolated from spleen and IEL and stained with -CD8, Thy1.1, and CD44 antibodies. Plots 
are gated on CD8+ lymphocytes. (E) Naive Thy1.1+ P14 were transferred to naive C57BL/6J mice. Control mice received normal drinking water, whereas 
treated mice were exposed to 2 µg/ml FTY720 in the drinking water ad libitum for the duration of the experiment. The next day, both groups of mice were 
immunized with LCMV, and 47 expression among Thy1.1+ P14 in spleen was compared among control mice (black line), FTY720-treated mice (dashed 
line), and CD44lo CD8 T cells isolated from spleens of naive mice (gray histogram). Plots are gated on Thy1.1+ CD8+ lymphocytes. All data are representative  
of two experiments with at least three mice per group in each experiment.558 Resident mucosal memory from systemic immunization | Masopust et al.
LCMV-immune P14 chimeras (generated as described in   
Fig. 1 A) were treated with FTY720 for 2 or 30 d in drinking 
water. As shown in Fig. 5 A, treatment led to a rapid deple-
tion of memory CD8 T cells in blood within 2 d, and this   
reduction was maintained for 30 d with continuous FTY720 
treatment (Fig. 5 B). As expected, a reciprocal increase in P14 
was observed in iLN, suggesting that lymphocyte recircula-
tion through the iLN was interrupted. However, there was 
no reduction in the number of P14 IEL, even after 30 d of 
treatment (Fig. 5, A and B). These data support the hypothe-
sis that IELs do not recirculate via afferent lymphatics.
We wished to independently test whether memory CD8 
T cells recirculated through gut epithelium over a period of 
several weeks. To this end, we removed 7 cm of small intes-
tine from naive C57BL/6J mice and transplanted this tissue 
into C57BL/6J mice that had been immunized with LCMV 
2 mo previously and contained large numbers of Thy1.1+ 
memory P14 CD8 T cells (Fig. 5 C). Blood vessels were li-
gated upon transplantation and donor gut remained viable and 
appeared healthy by visual inspection upon cessation of the 
experiment. This method allowed us to test whether memory 
CD8 T cells, which are present in all tissues of the recipient 
homing to intestinal epithelium, P14 cells derived from mLN 
were the most efficient, and iLN-derived cells migrated poorly. 
P14 derived from spleen exhibited an intermediate ability to traf-
fic to mucosal epithelium. When one considers the fact that there 
are 20-fold more early effector T cells in spleen than mLN, it 
is likely that more IEL effectors are derived from spleen than 
from mLN after an LCMV infection. To test this hypothesis, all 
lymphocytes derived from one spleen versus all mLNs derived 
from one mouse were transferred into separate recipients.   
Although recovery varied among different experiments, transfer 
of spleen consistently resulted in 2.5–4-fold more P14 within the 
gut epithelium than the transfer of mLN on a per-organ basis 
(Fig. 4 D, n = 5 per group for the experiment shown).
Memory IELs are resident
FTY720 treatment causes an accumulation of recirculating 
lymphocytes  within  lymphoid  tissue  and  a  corresponding   
decrease within other tissues that contain recirculating lym-
phocytes (Schwab and Cyster, 2007). To further test whether 
IELs  recirculate,  we  treated  LCMV-immune  mice  with 
FTY720 and examined whether treatment induced a reduc-
tion in memory CD8 T cells within the intestinal epithelium. 
Figure 4.  Memory CD8 T cells do not retain 47 expression regardless of anatomical location or immunization route. (A and B) Expression 
of 47 and/or CCR9 by P14 isolated from various tissues 4.5, 7, or 60 d after i.p. LCMV infection (A) or by OT-I after oral LMova infection (B). All plots 
are gated on Thy1.1+ CD8+ lymphocytes. (C) 106 Thy1.1+ P14 isolated from spleen (red), iLN (blue), or mLN (green) 4.5 d after LCMV infection was trans-
ferred to naive mice. The next day, lymphocytes were harvested from recipient spleen and small intestinal epithelium, and the proportion of CD8+  
lymphocytes that were Thy1.1+ was determined. Only p-values of <0.05 are shown. (D) Recipient mice received the entire single cell suspension derived 
from either one spleen or the complete cluster of mLN derived from one mouse isolated 4.5 d after LCMV infection. The next day, the proportion of CD8+ 
lymphocytes that were Thy1.1+ was determined. Error bars indicate SEM. All data are representative of at least two experiments with at least three mice 
per group in each experiment.JEM VOL. 207, March 15, 2010 
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Figure 5.  Memory CD8 T cells in intestinal epithelium do not recirculate. Naive P14 cells were transferred to naive C57BL/6J mice, and recipients 
were infected with LCMV. 90 d later, 2 µg/ml FTY720 was dissolved in drinking water (white bars) or mice were maintained on normal drinking water 
(black bars). (A and B) 2 (A) or 30 (B) d after FTY720 treatment, the number of LCMV-specific P14 memory CD8 T cells was determined in blood (PBL), iLNs, 
lung, or small intestinal epithelium (IEL). Data shown is one of five experiments with three mice per group with similar results. Immune mice were gener-
ated by transferring naive Thy1.1+ P14 into naive C57BL/6J mice and infecting recipients with LCMV. Error bars indicate SEM. *, P < 0.05; **, P < 0.01; ***,  
P < 0.001, unpaired Student’s t test. (C) 2 mo later, 7 cm of small intestine, along with associated mesentery and mLN, were transplanted from naive mice 
into immune mice. (D) 42 d after transplantation, lymphocytes were isolated from host spleen, blood (PBL), mLN, and intestinal epithelium (IEL), as well as 
donor mLN and IEL. The presence of host memory P14 was determined in each tissue by Thy1.1 staining and flow cytometry. All plots are gated on CD8+ 
lymphocytes and are representative of one of a total of three mice examined in two independent experiments. NA, not applicable.
mouse, would equilibrate with donor gut epithelium. Associ-
ation of donor small intestine with donor mLN remained in-
tact and served as a positive control for recirculation between 
graft and host. 42 d after transplantation, host and donor tis-
sues were removed and assessed for the presence of host mem-
ory P14. As shown in Fig. 5 D, donor mLNs have similar 
frequencies of memory P14 CD8 T cells compared with host 
mLNs, as expected. Within the donors’ IEL compartment, 
there were far fewer host memory P14 CD8 T cells compared 
with host epithelium, indicating minimal recirculation.560 Resident mucosal memory from systemic immunization | Masopust et al.
located in other tissues (Sallusto et al., 2004). Rather, the 
population is maintained in situ, which may have implica-
tions for the longevity of in situ protective immunity.
Local lymphoid tissue preferentially induces expression of 
homing molecules that help target activated T cells to associ-
ated nonlymphoid tissues (Butcher and Picker, 1996; von 
Andrian and Mackay, 2000). This has been best characterized 
in response to immunization with nonreplicating agents or in 
vitro. Our data extend these findings by demonstrating that 
T cells activated in vivo in response to a viral or bacterial   
infection also exhibit distinct homing properties that are   
dependent on the lymphoid environment within which they 
are primed (Fig. 4). However, our data demonstrates that 
priming within local lymphoid tissue may not be required for 
homing into the gut epithelium (Fig. 1–4). Rather, priming   
in spleen, a central lymphoid organ which contains the major-
ity of antigen-experienced CD8 T cells even after local infec-
tions (Haanen et al., 1999; Marshall et al., 2001; Masopust 
et al., 2004), results in a promiscuous homing program that 
drives migration to the intestinal mucosa with intermediate 
efficiency (Fig. 4 and Fig. S5). This observation may help 
reconcile  the  many  studies  demonstrating  the  distinctive 
homing properties of T cells primed in intestinal versus skin 
draining lymphoid tissue (Campbell and Butcher, 2002; Mora 
et al., 2003, 2005) and those studies that have demonstrated 
promiscuous T cell distribution after local infections (Stevceva 
et al., 2002; Masopust et al., 2004; Liu et al., 2006). Our   
results do not exclude other possible mechanisms that could 
contribute to the dissemination of effector T cell responses, 
including  recirculation  of  dendritic  cells  or  early  effector   
T cells through different LNs, where they may access a variety 
of homing signals (Belyakov et al., 2004; Liu et al., 2006). 
Defining what conditions regulate the establishment of intes-
tinal CD8 T cell memory after nonoral routes of immuniza-
tion will have obvious ramifications for vaccination.
In contrast to LNs, spleen does not drain tissues via the 
lymphatic system, nor is it directly associated with any particu-
lar body surface. Therefore, induction of a promiscuous hom-
ing program after activation within this tissue makes sense 
both teleologically and mechanistically and may enhance host 
immunity by ensuring that adaptive T cell responses examine 
all tissues for infection. Of course it remains quite possible that 
repeated infections, which may limit T cell reactivation to   
local tissues, could enhance the preferential accumulation of 
memory T cells specifically at the original site of infection. It 
is more difficult to speculate on the advantage of restricting 
recirculation through intestinal epithelium (Fig. 5), as this pre-
sumably limits the immediate availability of memory CD8   
T cells in the event of local reinfection. It may be related to 
the fact that the function and differentiation state of small   
intestine IELs differs markedly from memory CD8 T cells in 
blood (Masopust et al., 2006). Regardless, the observation that 
the potential to home to the gut epithelium dissipates shortly 
after pathogen control highlights how quickly CD8 T cell hom-
ing properties change throughout the response (Figs. 1–4). 
These rapid changes in homing potential and 47 expression 
Dynamic 47 and CLA expression after human s.c. yellow 
fever vaccination
Our observations in mice revealed that 47 was expressed 
by early effector CD8 T cells but not memory CD8 T cells. 
Expression of the putative skin homing molecule, functional 
P-selectin ligand, was similarly dynamic and was coexpressed 
with 47 on effector splenocytes shortly after LCMV infec-
tion (Fig. S5). We wished to examine whether expression of 
peripheral homing molecules was also dynamic after a pri-
mary immunization of humans. To follow a primary CD8 T 
cell response in humans, we examined the response to the 
live attenuated yellow fever virus (YFV)–17D vaccine (Miller 
et al., 2008). We identified an HLA-A2–restricted immuno-
dominant epitope that we used to construct MHC class I   
tetramers. Volunteers were vaccinated s.c. and a tetramer+ 
population in PBMC could be visualized by day 11. Because 
immunization was delivered s.c., we examined expression of 
CLA, which is involved in skin homing. CLA expression on 
YFV-specific T cells was remarkably transient, peaking on 
day 11, decreasing substantially by day 14, and was not   
detectable by day 30 after immunization (Fig. 6 A). When 
CD8 T cells were costained for both CLA and 47 mole-
cules, early effectors expressed detectable levels of both hom-
ing molecules (Fig. 6 B). However, by day 30, YFV-specific 
effector  CD8  T  cells  had  predominantly  down-regulated 
CLA and 47, and this phenotype persisted among memory 
CD8 T cells (90 d after infection; Fig. 6 C). Thus, human   
virus-specific CD8 T cells also express a very dynamic pattern 
of homing molecule expression and support the hypothesis 
that CD8 T cell homing to body surfaces occurs predomi-
nantly upon recent activation.
DISCUSSION
Our data support a model by which early effector CD8   
T cells migrate into the intestinal mucosa and then down-
regulate 47, differentiate into long-lived memory CD8   
T cells in situ, and remain resident without recirculating. 
Analysis of a primary human immune response to s.c. immu-
nization suggests that these migration dynamics reflect what 
occurs at other body surfaces, such as skin, which may also 
harbor resident memory CD8 T cells (Clark et al., 2006). 
This observation has several implications. Obviously, analysis 
of blood-borne lymphocytes will not reflect the quantity and 
quality of nonrecirculating T cells in tissues. Defining corre-
lates of cell-mediated protection after vaccination will require 
sampling T cells directly from portals of pathogen entry.   
The fact that memory CD8 T cells may remain sessile within   
intestinal epithelium supports the hypothesis that microenvi-
ronmental cues instruct their unique differentiation profile 
(Masopust et al., 2006). Most importantly, these data indicate 
that body surfaces must be seeded with memory T cell pre-
cursors shortly after priming or boosting, as memory T cells 
in other compartments will not equilibrate into this tissue. 
Consequently, in the absence of cognate antigen restimula-
tion, it is unlikely that peripheral memory is maintained by   
a stem cell–like population of central memory CD8 T cells JEM VOL. 207, March 15, 2010 
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molecule expression was similarly dynamic (Fig. 6). It remains 
important to determine whether long-term tissue residence 
will define the paradigm for memory T cells at other body 
surfaces, and how this relates to both control and pathogenesis 
of mucosal infections, such as HIV.
were defined in mouse studies that used various immunogens 
(LCMV, L. monocytogenes, influenza virus, and DNA vaccina-
tion) and routes of immunization (i.p., oral, intranasal, and   
intramuscular). When this principle was tested in humans in 
the context of a live attenuated vaccine, we found that homing 
Figure 6.  Primary human CD8 T cell response to s.c. yellow fever vaccine results in only short-term expression of 47 and CLA. Blood was 
isolated from HLA-A2–positive volunteers 11, 14, 30, and 90 d after s.c. vaccination with YFV-17D. (A) Expression of CLA versus staining with MHC class  
I tetramers that recognize YFV-specific CD8 T cells from three representative patients. (B) CLA versus 47 expression. HLA2-YFV tetramer+ cells are blue 
and HLA2-YFV tetramer cells are gray. Numbers indicate percentage of tetramer+ cells in each quadrant. All plots are gated on CD3+ CD8+ lymphocytes. 
(C) Summary of CLA and 47 expression among YFV tetramer+ cells. Longitudinal analysis is shown, although some patients were not examined on days 
30 and 90. Horizontal bars show the mean. Day 11, n = 7; day 14, n = 7; day 30, n = 4; day 90, n = 6.562 Resident mucosal memory from systemic immunization | Masopust et al.
In brief, intestinal grafts were transplanted by anastomosing the graft portal 
vein and superior mesenteric artery to the recipient inferior vena cava and 
infrarenal aorta, respectively. A stoma was formed from the proximal graft 
and the distal graft was anastomosed to the recipient jejunum.
Study subjects and blood samples. Blood samples were obtained from 
healthy volunteers (18–40 yr old) recruited after informed consent in a double-
blind controlled trial. The live-attenuated YFV-17D vaccine (YF-Vax) 
was administered alone or in combination with pooled immune serum glob-
ulin. Approval for all procedures was obtained from the Emory University 
Institutional Review Board. Exclusion criteria for subjects were a previous 
history of vaccination for or exposure to flaviviruses as indicated by serology, 
travel to endemic areas, and those recommendations established by the   
Advisory Committee on Immunization Practices and Vaccination. Samples 
were analyzed before and at various times after vaccination as indicated in the 
text. PBMCs were purified from CPT (BD) containers
Phenotyping of human YFV-specific CD8 T cells. HLA2-YFV–specific 
tetramers conjugated to streptavidin APC were prepared in house and used to 
stain 200–300 µl of whole blood. A 10-min incubation at room temperature 
was followed by addition of appropriate antibodies and a further 30-min   
incubation. The antibodies used were anti-CLA, -CD3, -CD8 (BD), or -47 
(clone ACT-1). Red blood cells were removed by lysing with FACS lysis buffer 
(BD) before washing cells with PBS. Samples were acquired on an LSRII flow 
cytometer (BD) and analyzed with FlowJo software (Tree Star, Inc.).
Online supplemental material. Fig. S1 shows that migration of early   
effector CD8 T cells to small intestinal epithelium is chemokine dependent. 
Fig. S2 shows that early effector CD8 T cells migrate from blood to small   
intestinal epithelium. Fig. S3 shows that effectors do not elicit bystander   
migration of memory cells to small intestinal epithelium. Fig. S4 shows that 
CD8 T cells gradually lose 47 expression after entry into small intestinal 
epithelium. Fig. S5 shows transient coexpression of functional P-selectin binding 
ligand and 47 among effector splenocytes. Online supplemental material is 
available at http://www.jem.org/cgi/content/full/jem.20090858/DC1.
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